Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.